For example, in the SELECT cardiovascular outcome trial studying people with obesity, the extent of weight loss did not correlate with the effects of the drug to reduce heart attack, stroke, and cardiovascular death . Also, another long-acting GLP-1 therapy, albiglutide, [was] withdrawn from the market owing to modest efficacy for reduction of glucose and body weight in people with T2D
With its launch in the Chinese market, more type 2 diabetes patients now have access to this novel therapeutic approach, improving their long-term diabetes management
By supporting GLP-1 pathways, ColonBroom encourages a sense of satiety without relying on synthetic hormones
During gastric bypass surgery, surgical staples are used to create a small pouch in the top part of the stomach
Are GHK-Cu injectable results permanent